The Effect of Time-Restricted Eating in Cardiometabolic Health

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age25-75
SponsorCambridge University Hospitals NHS Foundation Trust

About this trial

Time-restricted eating (TRE) is a dietary manipulation that involves restricting food intake to 6-12 h/day with no energy intake the rest of the day. In rodents, TRE improves metabolic function without caloric restriction, potentially by activating nutrient sensing mechanisms and effects on circadian oscillations. However, an understanding of the effect of TRE on cardiometabolic health in people is not clear and few studies have evaluated this issue. Accordingly, the investigators propose to conduct a randomized controlled trial in people with obesity and prediabetes to determine the effect of 9 h TRE for 12 weeks, without a change in body weight, on key metabolic outcomes that are risk factors for cardiovascular disease (CVD): 1) multi-organ insulin sensitivity; 2) 24 h metabolic homeostasis and diurnal rhythm; and 3) adipose tissue and skeletal muscle biology. The proposed studies will elucidate the cardiometabolic implications of TRE in people with obesity and prediabetes.

Eligibility criteria

Qualifiers

must be able to grant voluntary informed consent and comply with the study instructions

aged 25-75 years

men and women

body mass index 27-45 kg/m2

Disqualifiers

shift worker

fasting >12 h/day more than once a week

vegan

> once a week no food intake after ~1800 h

Trial design

Treatments tested in this trial

  • Time restricted eating
  • Extended eating window
  • Healthy diet

Treatment groups

100 Participants
are divided into 2 treatment groups